Leaders clash on mental health parity final rule

The latest stories trending on MedCity News.

Editor's Pick

Top Story Healthcare Leaders Clash on Mental Health Parity Final Rule The AMA came out in support of the Biden-Harris Administration's final rule on mental health parity, while AHIP and the Blue Cross Blue Shield Association argue that it will increase costs and negatively affect access to care. Sponsored Accelerating Claim Processing: Strategies to Shorten the Life of a Claim Presented by Greenway Health These strategies and practices can significantly shorten the life cycle of claims, leading to quicker resolutions and improved financial outcomes.  Learn More. Time is Running Out: INVEST Digital Health is Just One Week Away! We're preparing an extraordinary experience that you simply can't afford to miss!   Get ready to be a part of something truly exceptional at INVEST Digital Health, next week, Wednesday, September 18!    Healthcare's finest will be there. Will you?    Last Week to Register - Get Your Ticket NOW

Featured News

Get Ready for HLTH 2024: A Preview Guide HLTH 2024, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, will highlight new programming, a physicians roundtable, generative AI, the shifting landscapes of telemedicine, retail health, women's health, and lots more. Why Digital Health Startups Should Start Thinking About Their Reimbursement Pathway Earlier Some of the most difficult processes for digital health startups to navigate are those related to reimbursement and coding. Startups will often need to create entirely new codes for their products, so they should start thinking about this sooner rather than later, experts said at a recent conference. Bayer Asset Gives Roivant Sciences' New 'Vant' a Shot at Besting a United Therapeutics Lung Drug Roivant Sciences subsidiary Pulmovant is on track for a Phase 2 test of mosliciguat as a treatment for pulmonary hypertension associated with interstitial lung disease. The inhaled drug offers a different mechanism of action and less burdensome dosing compared to United Therapeutics' blockbuster PH-ILD drug, Tyvaso. Parenting: The New Mental Health Threat? A CEO and father of two reflects on the Surgeon General's recent advisory, evolving pressures on today's parents and the impact on mental health. Medicare Advantage Audit Ready with AI Adding generative AI and other AI tools to coding and chart review practices streamlines a complex process and better positions plans for risk adjustment audits.

Resources

MedCity FemFwd: Inside WHAM & KPMG's Women's Health Partnership In this episode, we're joined by Carolee Lee, CEO and founder of Women's Health Access Matters (WHAM), and Ash Shehata, KPMG U.S. sector leader for healthcare. The two discuss WHAM and KPMG's new partnership that aims to advance women's health research and investment. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe